- Home
- STE
as 07-26-2024 4:00pm EST
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
| Founded: | 1985 | Country: | Ireland |
| Employees: | N/A | City: | DUBLIN |
| Market Cap: | 22.6B | IPO Year: | 1992 |
| Target Price: | $244.33 | AVG Volume (30 days): | 414.8K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 3.81 | EPS Growth: | 256.07 |
| 52 Week Low/High: | $195.47 - $254.00 | Next Earning Date: | 08-06-2024 |
| Revenue: | $5,138,701,000 | Revenue Growth: | 13.28% |
| Revenue Growth (this year): | 8.69% | Revenue Growth (next year): | 5.51% |
Stock Insider Trading Activity of STERIS plc (Ireland) (STE)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Madsen Julia | STE | Senior VP, Life Sciences | Jun 5 '24 | Sell | $230.00 | 3,252 | $747,960.00 | 9,671 | SEC Form 4 |
| Madsen Julia | STE | Senior VP, Life Sciences | Jun 5 '24 | Sell | $230.00 | 400 | $92,000.00 | 9,671 | SEC Form 4 |
| Tamaro Renato | STE | V.P. & Corporate Treasurer | May 16 '24 | Sell | $231.64 | 1,154 | $267,312.56 | 6,677 | SEC Form 4 |
| FELDMANN CYNTHIA L | STE | Director | May 15 '24 | Sell | $237.65 | 2,000 | $475,300.00 | 705 | SEC Form 4 |
| TOKICH MICHAEL J | STE | Sr. Vice Pres., CFO | May 15 '24 | Sell | $233.34 | 5,039 | $1,175,800.26 | 69,425 | SEC Form 4 |
| TOKICH MICHAEL J | STE | Sr. Vice Pres., CFO | May 15 '24 | Sell | $234.54 | 3,281 | $769,525.74 | 66,144 | SEC Form 4 |
| TOKICH MICHAEL J | STE | Sr. Vice Pres., CFO | May 15 '24 | Sell | $235.84 | 17,500 | $4,127,200.00 | 48,644 | SEC Form 4 |
| TOKICH MICHAEL J | STE | Sr. Vice Pres., CFO | May 15 '24 | Sell | $236.22 | 6,180 | $1,459,839.60 | 42,464 | SEC Form 4 |
| Sohi Mohsen | STE | Director | May 14 '24 | Sell | $232.96 | 599 | $139,543.04 | 23,799 | SEC Form 4 |
| Sohi Mohsen | STE | Director | May 14 '24 | Sell | $234.04 | 1,438 | $336,549.52 | 22,361 | SEC Form 4 |
| Burton Karen L | STE | VP & CAO | May 14 '24 | Sell | $235.95 | 3,000 | $707,850.00 | 3,759 | SEC Form 4 |
| KOSECOFF JACQUELINE B | STE | Director | May 13 '24 | Sell | $231.53 | 4,584 | $1,061,333.52 | 0 | SEC Form 4 |
| Majors Cary L | STE | SVP and President, Healthcare | May 13 '24 | Sell | $232.13 | 2,024 | $469,831.12 | 11,369 | SEC Form 4 |
Latest STERIS plc (Ireland) News
STE Breaking Stock News: Dive into STE Ticker-Specific Updates for Smart Investing
Simply Wall St.
11 hours ago
This Is Why We Think STERIS plc's (NYSE:STE) CEO Might Get A Pay Rise Approved By Shareholders
Argus Research
3 days ago
STE: Raising target price to $243.00
GlobeNewswire
3 days ago
STERIS to Host a Conference Call for Fiscal 2025 First Quarter Financial Results on August 7, 2024
Zacks
3 days ago
Here's How STERIS (STE) is Placed Ahead of Q1 Earnings
Argus Research
10 days ago
STE: Raising target price to $239.00
Simply Wall St.
11 days ago
An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 31% Undervalued
Zacks
15 days ago
STERIS (STE) AST Business Expands, New Offerings Aid Growth
Argus Research
17 days ago
STE: Raising target price to $224.00
Compare STE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "STE STERIS plc (Ireland) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.